Symptomatic hyperekplexia in a patient with multiple sclerosis

Neurology

Volumn 58, Issue 3, 2002, Pages 503-504

  Ruprecht, Klemens ^a   Warmuth Metz, Monika ^a   Waespe, Walter ^a   Gold, Ralf ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; BETA INTERFERON; CITALOPRAM; GABAPENTIN; GADOLINIUM;

ADULT; ARTICLE; AUDITORY STIMULATION; CASE REPORT; CLINICAL FEATURE; CONTRAST ENHANCEMENT; ELECTROPHYSIOLOGY; FEMALE; HUMAN; MULTIPLE SCLEROSIS; MYOCLONUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETICULOSPINAL TRACT; STARTLE EPILEPSY; VISUAL STIMULATION;

EID: 0037065768     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.58.3.503     Document Type: Article

References (7)

1. Mutations in the alpha 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia
2. Schreckreflex und Schreckreaktion als hirnorganische Zeichen
3. The hyperekplexias and their relationship to the normal startle reflex
4. Hypertension, hyperekplexia, and pyramidal paresis due to vascular compression of the medulla
5. Startle syndromes
6. An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients
7. Beneficial effect of fluoxetine in a case of sporadic hyperekplexia